Cargando…

Aetiological and morphological spectrum of cardiomyopathies in French Guiana: a retrospective study

INTRODUCTION: Cardiomyopathies are a heterogeneous heart diseases group in terms of morphology and aetiology. Hypothesising a tropical specificity and given an absence of data in French Guiana, the primary objective of our study was to describe morphologies and aetiologies of cardiomyopathies observ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leménager, Paul, Franck, Yves-Kenol, Corlin, Florine, Bouscaren, Nicolas, Nacher, Mathieu, Adenis, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228657/ https://www.ncbi.nlm.nih.gov/pubmed/32404486 http://dx.doi.org/10.1136/openhrt-2019-001206

Ejemplares similares

Tip of the iceberg: a tertiary care centre retrospective study of left ventricular hypertrophy aetiologies
por: Beneyto, Maxime, et al.
Publicado: (2021)

The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure
por: Binas, David, et al.
Publicado: (2018)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

Early prediction of left ventricular function improvement in patients with new-onset heart failure and presumed non-ischaemic aetiology
por: Goh, Ze Ming, et al.
Publicado: (2023)

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR
por: Suwa, Kenichiro, et al.
Publicado: (2014)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
por: Lauppe, Rosa Elisabeth, et al.
Publicado: (2021)

Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy
por: Graziosi, Maddalena, et al.
Publicado: (2022)

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
por: Damy, Thibaud, et al.
Publicado: (2016)

Results of comprehensive diagnostic work-up in ‘idiopathic’ dilated cardiomyopathy
por: Broch, Kaspar, et al.
Publicado: (2015)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Hospitalisation and life support in the year before and during heart transplantation: a French national study
por: Cantrelle, Christelle, et al.
Publicado: (2018)

Repetitive squatting exercise as a diagnostic predictor in patients with dilated cardiomyopathy
por: Sveric, Krunoslav Michael, et al.
Publicado: (2018)

Systematic review and meta-analysis of prolactin and iron deficiency in peripartum cardiomyopathy
por: Cherubin, Sinaida, et al.
Publicado: (2020)

Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy
por: Camaioni, Claudia, et al.
Publicado: (2020)

Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy
por: Salazar-Mendiguchía, Joel, et al.
Publicado: (2020)

Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy
por: Liu, Tong, et al.
Publicado: (2021)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy
por: Tateishi, Emi, et al.
Publicado: (2015)

Stress-coping skills and neuroticism in apical ballooning syndrome (Takotsubo/stress cardiomyopathy)
por: Scantlebury, Dawn C, et al.
Publicado: (2016)

Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2020)

Cardiomyopathy associated with the Ala143Thr variant of the α-galactosidase A gene
por: Valtola, Kati, et al.
Publicado: (2020)

Clinical profile and prognostic factors of alcoholic cardiomyopathy in tribal and non-tribal population
por: Dungdung, Ajit, et al.
Publicado: (2020)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

The influence of aortoseptal angulation on provocable left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
por: Critoph, Christopher Howell, et al.
Publicado: (2014)

Novel genotype–phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy
por: Lopes, Luis R, et al.
Publicado: (2015)

Demographic features and prevalence of myocarditis in patients undergoing transarterial endomyocardial biopsy for unexplained cardiomyopathy
por: Hassan, Ayman K.M., et al.
Publicado: (2017)

Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy
por: Fan, Peng, et al.
Publicado: (2021)

CMR feature tracking in patients with dilated cardiomyopathy: patterns of myocardial strain and focal fibrosis
por: Chevalier, Céleste, et al.
Publicado: (2022)

Characteristics and outcome of patients with COVID-19 complicated by Takotsubo cardiomyopathy: case series with literature review
por: Hegde, Shruti, et al.
Publicado: (2020)

Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
por: Adalsteinsdottir, Berglind, et al.
Publicado: (2020)

Association of early versus delayed normalisation of left ventricular ejection fraction with mortality in ischemic cardiomyopathy
por: Schiffer, Walter B, et al.
Publicado: (2021)

FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy
por: Makrutzki-Zlotek, Kamila, et al.
Publicado: (2023)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

MRI and serum high-sensitivity C reactive protein predict long-term mortality in non-ischaemic cardiomyopathy
por: Sadahiro, Taketaro, et al.
Publicado: (2015)

US CARDIOLOGIST AND PATIENT PERSPECTIVES ON COVID-19 TELEHEALTH PRACTICES FOR PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)
por: Mitter, Sumeet, et al.
Publicado: (2021)

Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
por: Law, Steven, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p5tipijoadicqvo0e66tl94g07